Literature DB >> 31149267

NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE.

F Dirilenoglu1, A Kahraman Akkalp2, H Bag3, T Atasever Rezanko2, Z Kucukodaci2.   

Abstract

CONTEXT: Noninvasive encapsulated anaplastic thyroid carcinomas (NE-ATCs) have been described in few case reports, and consistently associated with favorable outcome compared to the classical ATCs.
OBJECTIVE: Our aim is to remark a rare histological finding in ATCs, encapsulation, which has been associated with a favorable outcome.
DESIGN: We have documented a rare case of an NE-ATC with its clinical, pathological, and molecular features. We also provided a thorough discussion of all the encapsulated ATCs reported in the literature. SUBJECTS AND METHODS: A 50-year-old woman with an unremarkable medical history, who presented with a thyroid nodule, and diagnosed as "follicular lesion of undetermined significance" by fine needle aspiration biopsy. The patient was lost to follow-up for six years and revisited upon her neck disturbances and underwent total thyroidectomy.
RESULTS: Sections of the right lobe revealed a grossly encapsulated nodular lesion, measuring 75x55x55 mm. Histologically, the tumor consisted of both carcinomatous and sarcomatous components supported by immunohistochemical stains. Necrosis and atypical mitotic figures were evident. Capsular and/or vascular invasion was not identified. There were no BRAF codon 600, KRAS, NRAS mutations and RET/PTC rearrangement. During three-month follow-up, the patient was free of disease without adjuvant therapy.
CONCLUSION: Encapsulated ATCs tend to follow a favorable clinical course and may deserve conservative treatment approaches.

Entities:  

Keywords:  anaplastic carcinoma; capsule; carcinosarcoma; good prognosis; noninvasive; thyroid

Year:  2018        PMID: 31149267      PMCID: PMC6516515          DOI: 10.4183/aeb.2018.255

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  11 in total

1.  Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?

Authors:  R Michael Tuttle; Bryan Haugen; Nancy D Perrier
Journal:  Thyroid       Date:  2017-05-19       Impact factor: 6.568

2.  Encapsulated anaplastic thyroid carcinoma with three-year disease-free survival.

Authors:  L Guimarães; A Meneses; W Carrara; A Kefalás
Journal:  Pathol Res Pract       Date:  2000       Impact factor: 3.250

Review 3.  Noninvasive anaplastic thyroid carcinoma: report of a case and literature review.

Authors:  Gregory Dibelius; Saral Mehra; Jason B Clain; Mark L Urken; Bruce M Wenig
Journal:  Thyroid       Date:  2014-07-02       Impact factor: 6.568

4.  Anaplastic thyroid carcinoma survival.

Authors:  P E Voutilainen; M Multanen; R K Haapiainen; A K Leppäniemi; A H Sivula
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

5.  Encapsulated anaplastic thyroid carcinoma without invasive phenotype with favorable prognosis: report of a case.

Authors:  Yasuhiro Ito; Fumio Matsuzuka; Hiroshi Yoshida; Shinji Morita; Keiichi Nakano; Kaoru Kobayashi; Tamotsu Yokozawa; Keisuke Hirai; Kennichi Kakudo; Kanji Kuma; Akira Miyauchi
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

6.  Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.

Authors:  I Sugitani; N Kasai; Y Fujimoto; A Yanagisawa
Journal:  World J Surg       Date:  2001-05       Impact factor: 3.352

7.  Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.

Authors:  Jennifer L Hunt; Michael Tometsko; Virginia A LiVolsi; Patricia Swalsky; Sydney D Finkelstein; E Leon Barnes
Journal:  Am J Surg Pathol       Date:  2003-12       Impact factor: 6.394

8.  Encapsulated anaplastic thyroid carcinoma transformed from follicular carcinoma: a case report.

Authors:  Amy Rapkiewicz; Daniel Roses; Alec Goldenberg; Pascale Levine; Michael Bannan; Aylin Simsir
Journal:  Acta Cytol       Date:  2009 May-Jun       Impact factor: 2.319

9.  Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992-2013.

Authors:  Anne-Michelle Noone; Kathleen A Cronin; Sean F Altekruse; Nadia Howlader; Denise R Lewis; Valentina I Petkov; Lynne Penberthy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-12       Impact factor: 4.254

10.  American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.

Authors:  Robert C Smallridge; Kenneth B Ain; Sylvia L Asa; Keith C Bible; James D Brierley; Kenneth D Burman; Electron Kebebew; Nancy Y Lee; Yuri E Nikiforov; M Sara Rosenthal; Manisha H Shah; Ashok R Shaha; R Michael Tuttle
Journal:  Thyroid       Date:  2012-11       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.